Company: AEMD
Filing Date: 2025-04-18
Form Type: DEF 14A
Source: 0001683168-25-002685
Chunk: 22

Company: AETHLON MEDICAL INC
Filing Date: 2025-04-18
Form: DEF 14A
Chunk 22
---
 the number of shares of our common stock outstanding resulting
from the Reverse Stock Split, and the market price per post-Reverse Stock Split share may not exceed or remain in excess of the $1.00
minimum bid price for a sustained period of time, and the Reverse Stock Split may not result in a per share price that would attract brokers
and investors who do not trade in lower priced stocks. In addition, although we believe the Reverse Stock Split may enhance the desirability
of our common stock to certain potential investors, it is possible that, if implemented, our common stock may not become more attractive
to institutional and other long term investors. Even if we implement the Reverse Stock Split, the market price of our common stock may
decrease due to factors unrelated to the Reverse Stock Split. In any case, the market price of our common stock may also be based on other
factors which may be unrelated to the number of shares outstanding, including our future performance. If the Reverse Stock Split is consummated
and the trading price of the common stock declines, the percentage decline as an absolute number and as a percentage of our overall market
capitalization may be greater than would occur in the absence of the Reverse Stock Split. Even if the market price per post-Reverse Stock
Split share of our common stock remains in excess of $1.00 per share, we may be delisted due to a failure to meet other continued listing
requirements, including Nasdaq requirements related to the minimum stockholder equity requirement, the minimum number of shares that must
be in the public float, the minimum market value of the public float and the minimum number of “round lot” holders.

The proposed Reverse Stock Split may decrease the liquidity of our common stock and result in higher transaction costs. The liquidity of our common stock may be negatively impacted
by a Reverse Stock Split, given the reduced number of shares that would be outstanding after the Reverse Stock Split, particularly if
the stock price does not increase as a result of the Reverse Stock Split. In addition, if a Reverse Stock Split is implemented, it will
increase the number of our stockholders who own “odd lots” of fewer than 100 shares of common stock. Brokerage commission
and other costs of transactions in odd lots are generally higher than the costs of transactions of more than 100 shares of common stock.
Accordingly, a Reverse Stock Split may not achieve the desired results of increasing marketability and liquidity of our common stock described
above.

If our stockholders approve